AML-190: Anti-TIM-3 Antibody MBG453 in Combination with Hypomethylating Agents (HMAs) in Patients with High-Risk Myelodysplastic Syndrome (HR-MDS) and Acute Myeloid Leukemia: A Phase 1 Study

Andrew M. Brunner, Uma Borate, Jordi Esteve, Kimmo Porkka, Steven Knapper, Norbert Vey, Sebastian Scholl, Martin Wermke, Jeroen Janssen, Elie Traer, Chong Chyn Chua, Rupa Narayan, Natalia Tovar, Mika Kontro, O. Ottman, Siyan Xu, Haiying Sun, Purushotham Naidu, Sebastian Szpakowski, Na Zhang, Anisa Mohammed, Mikael L. Rinne, Andrew H. Wei, Guillermo Garcia‐Manero